Does VERTEPORFIN Cause Disease recurrence? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Disease recurrence have been filed in association with VERTEPORFIN (Visudyne). This represents 1.6% of all adverse event reports for VERTEPORFIN.
12
Reports of Disease recurrence with VERTEPORFIN
1.6%
of all VERTEPORFIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Disease recurrence From VERTEPORFIN?
Of the 12 reports, 1 (8.3%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VERTEPORFIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does VERTEPORFIN Cause?
Visual acuity reduced (173)
Off label use (129)
Polypoidal choroidal vasculopathy (128)
Disease progression (115)
Age-related macular degeneration (90)
Retinal haemorrhage (70)
Product use in unapproved indication (57)
Choroidal neovascularisation (47)
Retinal detachment (42)
Subretinal fluid (42)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which VERTEPORFIN Alternatives Have Lower Disease recurrence Risk?
VERTEPORFIN vs VESICARE
VERTEPORFIN vs VFEND
VERTEPORFIN vs VIAGRA
VERTEPORFIN vs VIBEGRON
VERTEPORFIN vs VICODIN